Renal damage in antiphospholipid syndrome


Cite item

Full Text

About the authors

N A Meteleva

N L Kozlovskaya

References

  1. Hughes G. Я. V. Thrombosos, abortion, cerebral disease and lupus anticoagulant. Br. Med. J. 1983; 187: 1088-1089.
  2. Harris E. N., Gharavi A. E., Hughes G. R. et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-1214.
  3. Hughes G. R. V., Harris E. N, Gharavi A. E. The anticardiolipin syndrome. J. Rheumatol. 1986; 13: 486-489.
  4. Nochy D., Daugas E., Thi Huong D. L. et al. Kidney involvement in the antiphospholipid syndrome. J. Autoimmun. 2000; 15: 127-132.
  5. Мухин Н. А., Лысенко Л. В., Козловская Н. Л. и др. Поражение почек при антифосфолипидном синдроме. Врач 2002; 6: 13-18.
  6. Алекберова 3. С, Насонов Е. Л., Прудникова Л. 3. и др. Клиническое значение определения волчаночного анти- коагулянта и антител к кардиолипину. Тер. арх. 1988; 7: 84-86.
  7. Насонов Е. Л. Антифосфолипидный синдром: клиническая и иммунологическая характеристика. Клин. мед. 1989; 16: 5-13.
  8. Насонов Е. Л., Баранов А. А., Шилкина Н. П., АлекбероваС. Патология сосудов при антифосфолипидном синдроме (клиника, диагностика, лечение). М.; Ярославль, 1995.
  9. Калашникова Л. А., Насонов Е. Л., Кушекбаева А. Е. и др. Синдром Снеддона (связь с антителами к кардиолипину). Клин. мед. 1988; 10: 32-37.
  10. Калашникова Л. А., Насонов Е. Л., Борисенко В. В. и др. Синдром Снеддона: кардиальная патология и антифосфолипидные антитела. Клин. мед. 1988; 10: 32-27.
  11. Насонов Е. Л., Саложин К. В., Фомичева О. А. и др. Антиэндотелиальные антитела и поражение клапанов сердца при антифосфолипидном синдроме: анализ патогенетических механизмов. Клин. мед. 1997; 2: 17-22.
  12. Антифосфолипидный синдром в акушерской практике /Макацария А. Д., Бицадзе В. О., Гениевская М. Г. и др. М.: Руссо; 2000.
  13. Piette J. С, Cacoub P., Wechsler R. Renal manifestation of the antiphospholipid syndrome. Semin. Arthr. Rheum. 1994; 23: 357-366.
  14. Piette J. C, Kleinknecht D., Bach J.-F. Renal manifestation in the antiphospholipid syndrome. In: Asherson R., Cervera R.,Piette J. C, Schoefeld Y., eds. The antiphospholipid syndrome. Boca Raton: CRC Press; 1996. 169-181.
  15. Nzerue С M., Hewan-Lowe K, Pierangeli S., Harris E. N. "Black swan in the kidney": renal involvement in the antiphospholipid antibody syndrome. Kidney Int. 2002; 62 (3): 733- 744.
  16. Rabelink T. J., Zwaginga J. J., Koomans H. F. et al. Thrombosis and hemostasis in renal disease. Kidney Int. 1994; 46: 287- 296.
  17. Bellomo R., Atkins R. С. Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron 1993; 6 (3): 249-254.
  18. Appel G. В., Williams G. S., Meltzer J. I. et al. Renal vein thrombosis? Nephrotic syndrome and systemic lupus erythematosus: an association in four cases. Ann. Intern. Med. 1976; 85: 310-317.
  19. Glueck H. I., Kant K. S., Weiss M. A. et al. Thrombosis in systemic lupus erythematosus. Relation to the presence of circu lating anticoagulants. Arch. Intern. Med. 1985; 145: 1389- 1395.
  20. Perez R- E., McClendon J. R., Lie J. T. Primary antiphospholipid syndrome with multiorgan arterial and venous thrombosis.J. Rheumatol. 1993; 20: 874-876.
  21. Asherson R. A., Buchanan N., Baguleu E. et al. Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome. J. Rheumatol. 1993; 20: 1268-1272.
  22. Morgan R. J., Feneley С L. Renal vein thrombosis by primary antiphospholipid syndrome. Br. J. Urol. 1994; 74: 807-808.
  23. Espinosa G., Santos E., Cervera R. et al. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characrteristics of 86 patients. Medicine (Baltimore) 2003; 82 (2): 106-118.
  24. Pollak V. E., Weiss M. A. Renal vein thrombosis. In: TisherС. С, Brenner В. М., eds. Renal pathology with clinical and functional correlations. Philadelphia: J. B. Lippincott Comp; 1994; vol. 2: Ch. 37. 1185-1200.
  25. Козловская Н. Л., Медведева Т. Ю., Мирошниченко Н. Т.,Камалов Ю. Р. Тромбоз почечных вен мембранозной нефропатии. Тер. арх. 1995; 6: 71-73.
  26. Ostuni P. A., Lazzarin P., Pengo V. et al. Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. Ann. Rheum. Dis. 1990; 49: 184-187.
  27. Rysava R., Zabka J., Peregrin J. Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome. Nephrol. Dial. Transplant. 1998; 13: 2645-2647.
  28. Godfrey Т., Khamashta M. A., Hughes G. R. V. Antiphospholi pid syndrome and renal artery stenosis. Quart. J. Med. 2000; 93: 127-129.
  29. Remondino G. I., Mysler E., Pissano M. N. et al. A reversible bilateral renal artery stenosis in association with antiphospholipid syndrome. Lupus 2000; 9: 65-67.
  30. Sangle S. R., D 'Cruz D. P., Jan W. et al. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann. Rheum. Dis. 2003; 62: 999-1002.
  31. Rossi E., Sani C, Zini M. Anticardiolipin antibodies and renovascular hypertension. Ann. Rheum. Dis. 1992; 51: 1180b- 1181b.
  32. Cacoub P., Wechsler В., Piette J. С et al. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis. Clin. Exp. Rheumatol. 1993; 11 (5): 479-485.
  33. Asherson R. A., Nobel С E., Hughes G. R. V. Hypertension, renal artery stenosis and the "primary" antiphospholipid syndrome. J. Rheumatol. 1991; 18 (9): 1413-1415.
  34. Cacoub P., Piette J. C, Wechsler B. et al. Severe systemic hypertension due to renal artery lesion in systemic lupus erythematosus with antiphospholipid syndrome. Arthr. and Rheum. 1993; 36: 5186.
  35. George J., Shoenfeld Y. The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus 1997; 6: 559-560.
  36. Matsuura E., Kobayashi K, Koike Т., Shoenfeld Y. Autoantibodymediated atherosclerosis. Autoimmun. Rev. 2002; 1 (6V 348-353.
  37. Leaker В., McGregor A., Griffiths M. et al. Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis. Br. J. Rheumatol. 1991; 30: 422-425.
  38. Nochy D., Daugas E., Droz D. et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. JAm. Soc. Nephrol. 1999; 10: 507-518.
  39. Kolhe N., Downes M., О 'Donnell P., Carmichael P. Dead on biopsy is not always dead. Nephrol. Dial. Transplant. 2002; 17: 1843-1845.
  40. Hernandez D., Dominguez M. L., Diaz F. et al. Renal infarction in a severely hypertensive patient with lupus erythematosis and antiphospholipid antibodies. Nephron 1996; 72: 298-301.
  41. Amigo M.-C, Garcia-Torres R., Robles M. et al. Renal involvement in primary antiphospholipid syndrome. J. Rheumatol. 1992; 19: 1181-1185.
  42. Решетняк Т. М., Алекберова 3. С. Антифосфолипидный синдром: серологические маркеры, диагностические критерии, клинические проявления, классификация, прогноз. Тер. арх. 1998; 12: 74-78.
  43. Daugas E., Nochy D., ТЫ Huong D. L. et al. Antiphospholipid synrome nephropathy in systemic lupus erythematosus. J. Am. Soc. Nephrol. 2002; 13: 42-52.
  44. Moss К. Е., Isenberg D. A. Comparison of renal disease and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondry to systemic lupus erythematosus (SLE) and SLE alone. J. Rheumatol. 2001; 40: 863-867.
  45. Wilson W. A., Gharavi A. E., Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthr. and Rheum. 1999; 42: 1309-1311.
  46. Remuzzi G., Ruggenenti P. The hemolytic uremic syndrome. Kidney Int. 1995; 48: 2-19.
  47. Kant K. S., Pollak V. E., Weiss M. A. et al. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore) 1981; 60: 71-86.
  48. Frampton G., Hicks J., Cameron J. S. Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int. 1991; 39: 1225-1231.
  49. Kincaid-Smith P., Fairley К F., Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Quart. J. Med. 1988; 69: 795-815.
  50. Kleinknecht D., Bobrie G., Meyer O. et al. Recccurent thrombosis and renal vascular disease in patient with lupus anticoagulant. Nephrol. Dial. Transplant. 1989; 4: 854-858.
  51. Scolari F., Savoldi S., Costantino E. et al. Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis. Nephrol. Dial. Transplant. 1993; 8: 1274- 1276.
  52. Mandreoli M., Zucchelli P. Renal vascular disease in patients with primary antiphospholipid antibodies. Nephrol. Dial. Transplant. 1993; 8: 1277-1280.
  53. Durand J., Lefevre P., Kapcanski G. et al. Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature. Clin. Rheumatol. 1994; 13: 635-640.
  54. Domrongkitchaiporn S., Cameron E. C, Jetha N. et al. Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review. Nephron 1994; 68: 128- 132.
  55. Hamidov M. A., Moreau A., Jego P. et al. Captopril and aspirin in treatment of renal microangiopathy in primary antiphospholipid syndrome. Am. J. Kidney Dis. 1995; 25: 486-488.
  56. Sakaguchi S., Kitazawa K, Watanabe M. et al. A case of primary antiphospholipid syndrome with acute renal failure showing thrombotic microangiopathy. Am. J. Nephrol. 1999; 19: 594-598.
  57. Шилов Е. М., Козловская Н. Л., Метелева Н. А. и др. Клинические проявления нефропатии, связанной с антифосфолипидным синдромом, при первичном антифосфолипидном синдроме. Тер. арх. 2003; 6: 22-27.
  58. Levy Y., George J., Ziporen L. et al. Massive proteinuria as a main manifestation of primary antiphospholipid syndrome. Pathology 1998; 66 (1): 49-52.
  59. Козловская Н. Л., Шилов Е. М., Метелева Н. А., Шахнова E. А. Нефропатия, ассоциированная с антифосфолипидным синдромом: новая форма тромботического микрососудистого поражения почек. Materia Medica 2003; 1: 15- 23.
  60. Piette J. С. Venosus vs arterial/arteriolar APS subsets. Lupus 2002; 11:634.
  61. Rand J. H. Molecular pathogenesis of the antiphospholipid syndrome. Circ. Res. 2002; 90: 29-37.
  62. Meroni P. L., Raschi E., Camera M. et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J. Autoimmun. 2000; 15: 237-240.
  63. Griffiths M. H., Papadaki L., Neild G. H. The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury. Quart. J. Med. 2000; 93: 457-467.
  64. Sanna G., Bertolaccini M. L., Cuadrado M. J. et al. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 2003; 42: 200-213.
  65. Hess D. C, Shepard J. C, Adams R. J. Increased immunoglobulin binding to cerebral endotheliium in patients with aPL. Stroke 1993; 24: 994-999.
  66. Козловская Н. Л., Тареева И. Е., Камышова Е. С. и др. Поражение почек при первичном антифосфолипидном синдроме. Тер. арх. 2001; 6: 25-33.
  67. Appel G. В., Pirani С. L., D 'Agati V. Renal vascular complica tions of systemic lupus erythematosus. J. Am. Soc. Nephrol. 1994; 4: 1499-1515.
  68. Cshwartz M. M. Lupus vasculitis. Contrib. Nephrol. 1992; 99: 35-45.
  69. Farrugia E., Torres V. E., Gastineau D. Lupus antigcoagulant in systemic lupus erythematosus: a clinical and pathological study. Am. J. Kidney Dis. 1992; 5: 463-471.
  70. Hughson M. D., Nadasdy Т., McCarty G. A. et al. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am. J. Kidney Dis. 1992; 20: 150-158.
  71. Bhandari S., Hamden P., Brownjohn A. M. et al. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. Quart. J. Med. 1998; 91: 401-409.
  72. Love P., Santoro S. Antiphospholipid antibodies: anticardiolipin and lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann. Intern. Med. 1990; 112: 682-698.
  73. Bridoux F., Vrtocvsnik F., Noel С Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival. Nephrol. Dial. Transplant. 1998; 13: 298-304.
  74. Швецов М. Ю. Особенности синдрома артериальной гипертензии у больных волчаночным нефритом: Автореф. дис.канд. мед. наук. М.; 1998.
  75. Козловская Н. Л., Швецов М. Ю., Козловская Л. В. и др. Поражение почек у больных с антифосфолипидным синдромом при системной красной волчанке и первичным антифосфолипидным синдромом. В кн.: Мухин Н. А. (ред.) Успехи нефрологии. М.: ММА им. И. М. Сеченова; 2001. 227-236.
  76. Banfi G., Bertani Т., Boeri V. et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am.J. Kidney Dis. 1991; 18: 240-248.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2004 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies